AxoGen, Inc. (NASDAQ: AXGN) Starts Presentation at 29th Annual ROTH Conference
AxoGen (NASDAQ: AXGN) is engaged in innovative surgical solutions for peripheral nerve injuries. AxoGen's portfolio of products includes Avance®Nerve Graft, AxoGuard® Nerve Connector, AxoGuard® Nerve Protector, and Avive™ Soft Tissue Membrane. Along with these core surgical products, the company also offers AxoTouch™ Two-Point Discriminator and AcroVal™ Neurosensory & Motor Testing System. These evaluation and measurement tools assist health care professionals in detecting changes in sensation, assessing return of sensory, grip, and pinch function, evaluating effective treatment interventions, and providing feedback to patients on nerve function. The AxoGen portfolio of products is available in the United States, Canada, the United Kingdom, and several European and international…







